The Serbian tennis player Novak Djokovic has acquired 80% of the shares of the Danish pharmaceutical company QuantBioRes, a company that is investigating a medical treatment against Covid-19, just a few days after the closure of his controversial stay in Australia for the Grand Slam, to which the Australian Government ended by canceling his visa due to alleged irregularities in his documentation.